In MDD patients, there is synaptic loss and connectivity dysfunction (Holmes et al., 2019), and the significantly higher concentration of C3 and C3a in the peripheral plasma of medication‐free MDD groups suggest that complement signaling may also be implicated in the pathophysiology of MDD (Luo et al., 2022). This evidence concerns the gene C3 and major depressive disorder.